Q&A with George Llado, former Chief Information Officer of Alexion Pharmaceuticals

George Llado, former CIO of Alexion Pharmaceuticals, has joined the TileDB board, bringing over 30 years of IT and cybersecurity expertise from the biopharmaceutical industry. Llado's career spans leadership roles at Merck and Alexion, where he significantly contributed to their IT strategies and growth. He is enthusiastic about TileDB's potential as a market leader due to its innovative approach to multimodal data ingestion and analysis, which he sees as a game-changer in the pharma and biotech sectors. TileDB offers a unified data management platform that simplifies complex data handling, enabling faster insights and discovery, which is crucial for both large pharmaceutical companies and biotech startups. Llado believes that the ongoing advancements in AI, machine learning, and personalized medicine will be pivotal, with TileDB playing a key role in revolutionizing data analytics and drug discovery processes.